Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Stand if You Can: A Standing Intervention in Long Term Care

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03796039
Recruitment Status : Completed
First Posted : January 8, 2019
Results First Posted : July 6, 2021
Last Update Posted : July 13, 2021
Sponsor:
Collaborators:
Horizon Health Network
St. Thomas University
Universite de Moncton
Canadian Frailty Network
Information provided by (Responsible Party):
Danielle Bouchard, University of New Brunswick

Brief Summary:
It is currently unknown if reducing sitting time, an activity that is highly prevalent in frail older adults living in long term care (LTC) facilities, is associated with an improvement in physical capacity such as walking speed. Simple tasks such as walking speed is associated with important outcomes for residents in LTC such as autonomy and hospitalization. The investigators hypothesize that standing an additional 100 minutes per week for 5 months will result in a clinically meaningful improvement in walking speed (0.1m/sec) in LTC residents compared to residents receiving a sitting social activity.

Condition or disease Intervention/treatment Phase
Frailty Sedentary Behavior Physical Disability Behavioral: Standing Not Applicable

Detailed Description:
LTC facilities from Moncton and Fredericton will be recruited, with half of the LTC facilities randomized as the intervention and half as the control group. The investigators are aiming to enrol half of the LTC in Fredericton and half in Moncton. A total of 88 residents (44 in the control group, 44 in the intervention group) will be enrolled in the program.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 97 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Long term care (LTC) facilities will be recruited, with half of the LTC facilities randomized as the intervention (n=2) and half as the control group (n=2).
Masking: Single (Investigator)
Masking Description: Investigator was masked at pre-testing. It was unknown which participants would be receiving the intervention. However, due to resources this was not repeated at post testing
Primary Purpose: Supportive Care
Official Title: Stand if You Can- A Randomized Control Trial
Actual Study Start Date : April 1, 2019
Actual Primary Completion Date : January 23, 2020
Actual Study Completion Date : July 15, 2020

Arm Intervention/treatment
Experimental: Standing and Social Intervention
Participants be exposed to an additional 100 minutes of standing per week. Participants will do this by standing for 20 minutes Monday through Friday.
Behavioral: Standing
Standing for an additional 100 minutes per week; 20 minutes Monday-Friday

No Intervention: Control Group
Control group will receive social visits, but no exposure to standing



Primary Outcome Measures :
  1. Changes in Walking Speed [ Time Frame: Pre and post intervention testing ]
    Measured by the 10m walking speed test


Secondary Outcome Measures :
  1. Change in Balance [ Time Frame: Pre and post testing (following the 5 month intervention). Data was collected but investigators are still analyzing findings. ]
    Measured by a portable device (Wii Balance board), which has sensors that detects sway .

  2. Change in Leg Strength [ Time Frame: Pre-Post Testing (following the 5 month intervention) ]
    Using hand-held dynamometer to quantify leg strength through knee extension

  3. Change Lower Limb Power [ Time Frame: Pre-Post Testing (following the 5 month intervention) ]
    Using the 30second sit-stand test following senior fitness test protocol

  4. Change in Anxiety Symptoms [ Time Frame: Pre-Post Testing (following the 5 month intervention) ]
    The Geriatric Anxiety Inventory (Scale 0-20). A low score means a better outcome.

  5. Depression [ Time Frame: Pre-Post Testing (following the 5 month intervention) ]
    Geriatric Depression Scale Short Form (0-15 scale). Lower score is better outcome.

  6. Loneliness [ Time Frame: Pre-Post Testing (following the 5 month intervention) ]
    Loneliness was measured using the UCLA Loneliness Scale (20-80). A low score indicates a better outcome

  7. Fall Efficacy [ Time Frame: Pre-Post Testing (following the 5 month intervention) ]
    Falls Efficacy Scale-International Questionnaire (16-64 scale). Low score indicates a better score

  8. Rate of Falls [ Time Frame: The number of falls will be collected from three timeframes: 1. Between 6 months prior to and the start of program 2. the duration of the program (5 months) 3. From the end of the program to 6 months follow up. Data is still being analyzed at this time. ]
    Falls, injuries due to falls and hospitalization will be collected at 3 timepoints

  9. Metabolic Profile - Triglycerides [ Time Frame: Pre-Post Testing (before and following the 5 month intervention). ]
    Capillary blood analyzed with a cardiochek device. Blood collected via a finger prick and analyzed with a cardiochek device. Note that Total Cholesterol, HDL, Triglycerides, LDL and Glucose were all measured using the cardiochek device.

  10. Social Behaviours [ Time Frame: Pre-Post Testing (following the 5-month intervention). Data has been collected, but is still being analyzed ]
    Semi-structured interviews with residents (participants and non-participants), family members and staff will be administered at the end of the study

  11. Metabolic Profile - High Density Lipoprotein Cholesterol [ Time Frame: Pre and post testing (before and after the 5-month intervention) ]
    High Density Lipoprotein (HDL) cholesterol was analyzed using the CardioChek Professional Analyzer system (PTS Diagnostics, Whitestown, Indiana, USA). A finger prick was conducted using a single use lancet and approximately 60 µL of whole blood was collected for this test.

  12. Metabolic Profile - Low Density Lipoprotein Cholesterol [ Time Frame: Pre-Post intervention (before and after 5-month intervention) ]
    Low-density lipoprotein was assessed using a CardioChek Professional Analyzer system (PTS Diagnostics, Whitestown, Indiana, USA).

  13. Metabolic Profile - Blood Glucose [ Time Frame: Pre-Post Intervention (before and after 5-month intervention) ]
    Fasted blood glucose was analyzed using a CardioChek Professional Analyzer system (PTS Diagnostics, Whitestown, Indiana, USA).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Resident at one of the selected LTC facilities;
  • Able to provide consent or have a power of attorney agree on behalf of a resident to participate in the study;
  • Able to walk for ten meters, with or without a walking aid; The main outcome is walking speed performed for a distance of 10 meters. Therefore, we want everyone who participates in the study to be able to complete the test at baseline. This way we can answer the main research question, while adhering to our sample size calculation.

Exclusion Criteria:

  • If Identified by staff at the facility as too high risk for falling by participating in the intervention.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03796039


Locations
Layout table for location information
Canada, New Brunswick
Pine Grove Nursing Home
Fredericton, New Brunswick, Canada, E3B 2J2
Sponsors and Collaborators
University of New Brunswick
Horizon Health Network
St. Thomas University
Universite de Moncton
Canadian Frailty Network
  Study Documents (Full-Text)

Documents provided by Danielle Bouchard, University of New Brunswick:
Layout table for additonal information
Responsible Party: Danielle Bouchard, Associate Investigator, University of New Brunswick
ClinicalTrials.gov Identifier: NCT03796039    
Other Study ID Numbers: CAT2018-15
First Posted: January 8, 2019    Key Record Dates
Results First Posted: July 6, 2021
Last Update Posted: July 13, 2021
Last Verified: July 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Danielle Bouchard, University of New Brunswick:
Long Term Care
Physical Function
Additional relevant MeSH terms:
Layout table for MeSH terms
Frailty
Pathologic Processes